Skip to content

L. Bidwell

3 papers in the library · publishing 2024-2026

Papers

Sort Most recent Most cited

Effects of delta-9 tetrahydrocannabinol and cannabidiol on cognitive outcomes following acute use of cannabis for chronic pain.

Psychopharmacology September 1, 2026 Renée Martin-Willett, Samantha N. Melendez, Kent E. Hutchison et al.

RATIONALE An estimated two-thirds of medical cannabis users in the United States are motivated by chronic pain, but clinical guidance remains guarded as to whether the potential benefit of cannabinoids for pain outweighs potential risks, such as effects on cognition. OBJECTIVES In a study where participants experienced benefits of cannabinoids for pain and tension, we evaluated cannabis effects...

Inflammatory state moderates response to cannabis on negative affect and sleep quality in individuals with anxiety

Frontiers in Behavioral Neuroscience July 1, 2025 Richard G. Hunter, Annelise Madison, Jonathon K. Lisano et al.

Introduction Inflammation has been implicated as an underlying pathology in negative affect and sleep disruption. Cannabinoids like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have demonstrated anti-inflammatory properties. This study aimed to assess if cannabis use altered cytokine concentration and whether inflammatory status moderated the influence of 4 weeks of cannabis use on...

Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study

Cannabis and Cannabinoid Research January 22, 2024 L. Bidwell, Renée Martin-Willett, Carillon J. Skrzynski et al.

Objective: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have varying pharmacological actions with differential effects on acute and extended affective states, incuding anxiety. We aimed to study these effects on anxiety in legal market forms of cannabis. Method: This study makes use of a nonequivalent control group quasiexperimental design. Forty-two participants with anxiety symptions...